OVERVIEW

Amid the COVID-19 crisis, the global market for digital diabetes management is expected to grow over the forecast period at a CAGR of 21.2%. This market’s growth is driven primarily by growing diabetes prevalence, rising cases of coronavirus, increasing focus on developing and embracing electronic diabetes platforms, and technological advances. The report will also account for COVID-19 as a key market contributor.

TABLE OF CONTENT

• 2 RESEARCH METHODOLOGY
  • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions

• 3 Global Digital Diabetes Management Market ? Executive Summary
  • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography

• 4 Global Digital Diabetes Management Market ? Comparative Analysis
  • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis

• 5 Global Digital Diabetes Management Market ? Industry Market Entry Scenario
  • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis ? Top 10 companies

• 6 Global Digital Diabetes Management Market - Market Forces
  • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
    • 6.2.2 Opportunities
    • 6.2.3 Challenges
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes

• 7 Global Digital Diabetes Management Market - Strategic Analysis
  • 7.1 Value Chain analysis
  • 7.2 Product Life Cycle
  • 7.3 Supplier and distributor analysis (Market share and product dealing strategies)

• 8 Global Digital Diabetes Management Market ? By Component (Market Size ? &

• • 8.1 Devices
  • 8.2 Data Management Software & Platforms
  • 8.3 Services

• 9 Global Digital Diabetes Management Market - By Type
  • 9.1 Handheld Devices
  • 9.2 Wearable Devices

• 10 Global Digital Diabetes Management Market - By End-User
  • 10.1 Self/Home Healthcare
  • 10.2 Hospitals & Specialty Diabetes Clinics
  • 10.3 Academic & Research Institutes

• 11 Global Digital Diabetes Management Market ? By Geography (Market Size ? &

• • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 U.K
    • 11.3.2 Germany
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia-Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 South Korea
    • 11.4.5 Rest of APAC
  • 11.5 Rest of the World
    • 11.5.1 South America
    • 11.5.2 Middle East
    • 11.5.3 Africa

• 12 Global Digital Diabetes Management Market ? Entropy
  • 12.1 New product launches
  • 12.2 M&A's, collaborations, JVs and partnerships

• 13 Global Digital Diabetes Management Market Company Profile (Key Players)
  • 13.1 Market Share, Company Revenue, Products, M&A, Developments
  • 13.2 Medtronic PLC
  • 13.3 F. Hoffmann-La Roche
  • 13.4 Dexcom, Inc.
  • 13.5 Ascensia Diabetes Care Holdings Ag.
  • 13.6 Abbott Laboratories
  • 13.7 Lifescan, Inc. (A Subsidiary of Johnson & Johnson)
  • 13.8 Agamatrix, Inc.
  • 13.9 B. Braun Melsungen AG
  • 13.10 Glooko, Inc.
  • 13.11 Tidepool
  • 13.12 Company 11 & more

• 14 Global Digital Diabetes Management Market - Appendix
  • 14.1 Sources
  • 14.2 Abbreviations